Financhill
Sell
31

HKHHY Quote, Financials, Valuation and Earnings

Last price:
$29.85
Seasonality move :
1.76%
Day range:
$29.78 - $30.06
52-week range:
$29.63 - $43.56
Dividend yield:
3.14%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.67x
Volume:
149.1K
Avg. volume:
95.6K
1-year change:
-29.11%
Market cap:
$16.9B
Revenue:
$32.9B
EPS (TTM):
--
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $26.8B $22.5B $26B $30.3B $32.9B
Revenue Growth (YoY) 1.05% -16.09% 15.3% 16.67% 8.53%
 
Cost of Revenues $16.3B $14.2B $16B $19.6B $21.7B
Gross Profit $10.5B $8.3B $9.9B $10.7B $11.1B
Gross Profit Margin 39.12% 36.85% 38.31% 35.17% 33.88%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $6.5B $7.5B $6.4B $6.3B $8.1B
Operating Income $4B $824.5M $3.5B $4.4B $3.1B
 
Net Interest Expenses $541.8M $548.2M $375.1M $304.8M $567.3M
EBT. Incl. Unusual Items $3.7B $179.3M $5.1B $4.4B $2.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1B $279.8M $945.4M $1.2B $131M
Net Income to Company $2.7B -$100.5M $4.2B $3.2B $2.6B
 
Minority Interest in Earnings -$1.4B -$16M -$2.2B -$1.8B -$1.3B
Net Income to Common Excl Extra Items $1.2B -$116.5M $2B $1.4B $1.3B
 
Basic EPS (Cont. Ops) $2.11 -$0.21 $3.41 $2.46 $2.23
Diluted EPS (Cont. Ops) $2.11 -$0.21 $3.41 $2.46 $2.23
Weighted Average Basic Share $576.1M $576.1M $576.1M $576.1M $567.9M
Weighted Average Diluted Share $576.1M $576.1M $576.1M $576.1M $567.9M
 
EBITDA $6.5B $4.1B $8B $6.9B $6.8B
EBIT $4.3B $785.7M $5.7B $4.9B $3.5B
 
Revenue (Reported) $26.8B $22.5B $26B $30.3B $32.9B
Operating Income (Reported) $4B $824.5M $3.5B $4.4B $3.1B
Operating Income (Adjusted) $4.3B $785.7M $5.7B $4.9B $3.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $29.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- $565.7M
Weighted Average Diluted Share -- -- -- -- $565.7M
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- $29.6B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $24B $24.5B $28B $31.4B $33B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) $24B $24.5B $28B $31.4B $33B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $29.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- $565.7M
Weighted Average Diluted Share -- -- -- -- $565.7M
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- $29.6B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $2B $4.9B $3.7B $3B $2.6B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.3B $2.2B $2.7B $3.3B $3.7B
Inventory $2.5B $2.4B $2.8B $3.5B $4.1B
Prepaid Expenses $431.3M $471.1M $461.9M $520.1M $588.1M
Other Current Assets -- -- -- -- --
Total Current Assets $9.4B $11.1B $10.8B $11.8B $12.6B
 
Property Plant And Equipment $14.9B $14.2B $14B $14.6B $16.3B
Long-Term Investments -- -- -- -- --
Goodwill $12.8B $13.1B $13.4B $13.1B $13.5B
Other Intangibles $7.1B $6.3B $10.1B $9.8B $10.5B
Other Long-Term Assets -- -- -- -- --
Total Assets $52.1B $52.4B $55.3B $56.2B $60.5B
 
Accounts Payable $5.3B $4.5B $5.2B $6.3B $6.3B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $285.6M $323.5M $289.8M $360.3M $338.3M
Other Current Liabilities $632.9M $558.4M $538.9M $584.5M $587M
Total Current Liabilities $13.8B $13.4B $13.7B $15.2B $16.4B
 
Long-Term Debt $13.8B $16.8B $14.5B $12.9B $14.5B
Capital Leases -- -- -- -- --
Total Liabilities $32.7B $34.7B $33B $32.7B $35.8B
 
Common Stock $516.4M $567M $522M $494.4M $509.6M
Other Common Equity Adj -- -- -- -- --
Common Equity $9B $8.1B $9.7B $10.4B $10.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $10.4B $9.6B $12.6B $13.1B $14B
Total Equity $19.4B $17.7B $22.3B $23.5B $24.8B
 
Total Liabilities and Equity $52.1B $52.4B $55.3B $56.2B $60.5B
Cash and Short Terms $2B $4.9B $3.7B $3B $2.6B
Total Debt $17.7B $20.9B $17.9B $16.2B $18.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- --
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- -- --
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- -- --
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- -- --
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- --
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- --
 
Total Liabilities and Equity -- -- -- -- --
Cash and Short Terms -- -- -- -- --
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $2.7B -$100.5M $4.2B $3.2B $2.6B
Depreciation & Amoritzation $2.2B $3.3B $2.3B $2B $3.4B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$274.3M $1.3B -$824.7M -$704.5M -$45.5M
Change in Inventories -$287.7M -$20.6M -$364.4M -$836.3M -$4.3M
Cash From Operations $4.9B $3.6B $4.9B $4.7B $4.8B
 
Capital Expenditures $2.4B $1.9B $1.9B $2.1B $2.9B
Cash Acquisitions -$3.1B $211.3M -$721.7M -$209.9M -$979.8M
Cash From Investing -$5.5B -$1.6B -$2.7B -$2.4B -$3.9B
 
Dividends Paid (Ex Special Dividend) -$1.4B -$926.2M -$941.8M -$1.2B -$1.4B
Special Dividend Paid
Long-Term Debt Issued $2.6B $6.9B $1.9B $679.2M $7.3B
Long-Term Debt Repaid -$2.4B -$4.2B -$4B -$2B -$5B
Repurchase of Common Stock -- -- -- -$45.3M -$1B
Other Financing Activities -$111.9M -$4.6M -$11.8M -$412.3M -$309.6M
Cash From Financing -$1.1B $1.4B -$3.4B -$3.3B -$883.4M
 
Beginning Cash (CF) $2.5B $784.6M $4.2B $2.7B $1.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.7B $3.4B -$1.2B -$967.1M $41.1M
Ending Cash (CF) $769.1M $4B $3B $1.7B $1.5B
 
Levered Free Cash Flow $2.5B $1.7B $3.1B $2.6B $1.9B
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $3.3B $5.2B $5.3B $3.5B $5.8B
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-12-23 2022-12-23 2023-12-23 2024-12-23 2025-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock